×
About 283 results

ALLMedicine™ Tubal Sterilization Center

Research & Reviews  96 results

Short-notice cancellations of laparoscopic permanent contraception.
https://doi.org/10.1016/j.contraception.2022.04.013
Contraception Masten M, Larrea N et. al.

May 12th, 2022 - Permanent contraception through tubal sterilization is the preferred contraceptive method for 25% of women in the United States. Laparoscopic permanent contraception has an anecdotally high cancellation rate. Cancellations affect operating room ut...

Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
https://clinicaltrials.gov/ct2/show/NCT03127722

May 6th, 2022 - This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization, including: Pelvic and/or lower abdominal pain Abnormal uterine bleeding Surg...

FemBloc® Permanent Contraception - Early Pivotal Trial
https://clinicaltrials.gov/ct2/show/NCT03433911

Apr 22nd, 2022 - Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The lapa...

Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for Ovarian Can...
https://doi.org/10.1097/SLA.0000000000005374
Annals of Surgery; Matsuo K, Chen L et. al.

Feb 8th, 2022 - To perform a cost-effectiveness analysis to examine the utility and effectiveness of opportunistic salpingectomy (OS) performed at the time of elective cholecystectomy (LAP-CHOL). OS has been adopted as a strategy to reduce the risk of ovarian can...

Gestational diabetes and intraoperative tubal sterilization are risk factors for high i...
https://doi.org/10.21037/apm-21-2139
Annals of Palliative Medicine; Nivatpumin P, Pangthipampai P et. al.

Dec 22nd, 2021 - Postcesarean delivery pain leads to several adverse maternal outcomes. The primary objective of this study was to determine the incidence of moderate-to-severe pain after the use of spinal morphine for cesarean delivery. The secondary aim was to i...

see more →

Clinicaltrials.gov  6 results

Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
https://clinicaltrials.gov/ct2/show/NCT03127722

May 6th, 2022 - This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization, including: Pelvic and/or lower abdominal pain Abnormal uterine bleeding Surg...

FemBloc® Permanent Contraception - Early Pivotal Trial
https://clinicaltrials.gov/ct2/show/NCT03433911

Apr 22nd, 2022 - Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The lapa...

"My Decision" Tubal Sterilization Decision Support Tool
https://clinicaltrials.gov/ct2/show/NCT04097717

Dec 15th, 2021 - Female surgical sterilization is the second most commonly used contraceptive method in the US and is disproportionately used by low-income women and women of color. Whether the higher use of sterilization in these populations reflects inappropriat...

Comparison of Results of Different Surgical Techniques Used in Female Tubal Sterilization
https://clinicaltrials.gov/ct2/show/NCT04332120

Apr 2nd, 2020 - The study compared the peroperative effects and postoperative results of different surgical techniques with three different techniques in patients undergoing tubal sterilization. surgical techniques used: Mini Laparotomic tubal ligation Laparoscop...

Intrauterine Lidocaine Infusion for Essure Sterilization Procedures
https://clinicaltrials.gov/ct2/show/NCT00613834

Dec 19th, 2019 - We intend to conduct a randomized, blinded, and placebo- controlled clinical trial at Oregon Health and Science University and Planned Parenthood of the Columbia Willamette to determine if intrauterine lidocaine infusion will decrease the amount o...

see more →

News  11 results

Fertility After Tubal Ligation — It's a Matter of 'AGE'
https://www.medscape.com/viewarticle/971121

Mar 29th, 2022 - Despite the original intent of permanent contraception, tubal sterilization regret is experienced by 2%-26% of women as demonstrated by the United States Collaborative Review of Sterilization "CREST" 14-year study (Obstet Gynecol. 1999 Jun;93[6]:8...

Social Media Complicate Ob/Gyn Care
https://www.medpagetoday.com/obgyn/generalobgyn/56689

Mar 11th, 2016 - Controversies over certain products and procedures in ob/gyn care may now be interfering with the doctor-patient relationship, according to two Boston-area physicians writing in Obstetrics and Gynecology. Mesh implants, the use of power morcellati...

Salpingectomy May Prevent Ovarian Cancer, ACOG Says
https://www.medscape.com/viewarticle/837414

Dec 31st, 2014 - Removal of the fallopian tubes may help prevent ovarian cancer, according to an opinion written by the American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice. The opinion appears in the January 2015 issue of Obstetr...

Paradigm shift: Prophylactic salpingectomy for ovarian cancer risk reduction
https://www.mdedge.com/obgyn/article/87514/gynecologic-cancer/paradigm-shift-prophylactic-salpingectomy-ovarian-cancer-risk
Bruce Jancin

Sep 24th, 2014 - LAS VEGAS – Removing the fallopian tubes at the time of pelvic surgeries as a potential means of reducing ovarian cancer risk appears to be a movement that’s picking up steam in clinical practice. A recent survey of 234 U.

Salpingectomy With Hysterectomy May Reduce Cancer Risk
https://www.medscape.com/viewarticle/804735

May 24th, 2013 - NEW ORLEANS, Louisiana — Bilateral salpingectomy at the time of ovarian-preserving hysterectomy results in no increased morbidity and is becoming more accepted by patients and surgeons as a risk-reducing strategy for both serous carcinoma and adne...

see more →